Abstract
The combination of type 1 diabetes and bulimia nervosa has been referred to as ‘diabulimia’. The prognosis is poorer in subjects with comorbid disorder than those with isolated bulimia nervosa. Collaborative, integrated care is needed in the assessment and treatment of patients. In this review article we provide a formulation merging both the transdiagnostic and dual pathway models and discuss the latest evidence‐based management for patients with coexisting diagnoses.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
